Security key
918385204
vTv Therapeutics Inc. - Class A Common Stock, par value $0.01 per share (VTVT)
CUSIP: 918385204
Q4 2025 13F Holders as of 31 Dec 2025
- Security type / class
- Equity / Class A Common Stock, par value $0.01 per share
- Total 13F shares
- 1,283,622
- Total 13F value
- $51,331,670
- Share change
- +64,343
- SEC-reported price per share
- $39.99
- Number of holders
- 27
- Value change
- +$2,953,481
- Number of buys
- 14
- Number of sells
- 6
- Shares outstanding
- 3,911,217
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q4 2025
Institutions
27
Top holders
10
VTVT full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q1 2026
Previous quarter: Q3 2025
vTv Therapeutics Inc. SEC filings
vTv Therapeutics Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 918385204
Recent filing periods:
Ownership snapshot
Top reported holders of VTVT - vTv Therapeutics Inc. - Class A Common Stock, par value $0.01 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Samsara BioCapital, L.P.
Disclosed value leader
Samsara BioCapital, L.P.
Comparable rows
15/15
Latest evidence
08 Dec 2025
13D/G
13F
Lead comparable stake: 9.9%
13D/G row: Samsara BioCapital, L.P.
Showing 1-6 of 15 holder rows.
Quick read
Samsara BioCapital, L.P. leads the comparable SEC ownership view at 9.9%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Samsara BioCapital, L.P.'s linked filing trail.
Comparable ownership
Top 5
Samsara BioCapital, L.P.
9.9%
Trails Edge Capital Partners, LP
9.9%
Invus Global Management, LLC
9.4%
Samsara BioCapital, LLC
9.6%
FMR LLC
4.9%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Samsara BioCapital, L.P. |
13D/G
Srinivas Akkaraju
|
9.9%
|
$12,001,117
403,942 shares
|
+$1,803,961 | 08 Dec 2025 |
| Trails Edge Capital Partners, LP |
13D/G
|
9.9%
|
$5,108,040
340,536 shares
|
$0 | 29 Aug 2025 |
| Invus Global Management, LLC |
13D/G
Raymond Debbane
|
9.4%
|
$9,179,310
393,098 shares
|
+$1,051,154 | 30 Sep 2025 |
| Samsara BioCapital, LLC |
13F
Company
|
9.6%
|
$8,743,664
374,461 shares
|
— | 30 Sep 2025 |
| FMR LLC |
13F
Company
|
4.9%
|
$4,487,609
192,891 shares
|
— | 30 Sep 2025 |
| Siren, L.L.C. |
13F
Individual
|
4.2%
|
$3,806,050
163,000 shares
|
— | 30 Sep 2025 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q4 2025
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
27
Shares
1,283,622
Rows available
27
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q4 2025 vs Q3 2025 Across Filers
Q3 2025 holders
23
Q4 2025 holders
27
Holder diff
4
| Investor | Q3 2025 Shares | Q4 2025 Shares | Share Diff | Share Chg % | Q3 2025 value | Q4 2025 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend